.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Medtronic
AstraZeneca
US Department of Justice
Chinese Patent Office
Accenture
Cipla
Novartis
Mallinckrodt
Harvard Business School

Generated: July 23, 2017

DrugPatentWatch Database Preview

CHILDREN'S ZYRTEC HIVES RELIEF Drug Profile

« Back to Dashboard

Which patents cover Children's Zyrtec Hives Relief, and when can generic versions of Children's Zyrtec Hives Relief launch?

Children's Zyrtec Hives Relief is a drug marketed by J And J Consumer Inc and is included in two NDAs. There is one patent protecting this drug.

This drug has twenty-two patent family members in nineteen countries.

The generic ingredient in CHILDREN'S ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and sixty suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for Tradename: CHILDREN'S ZYRTEC HIVES RELIEF

Patents:1
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list49
Clinical Trials: see list8,292
Patent Applications: see list3,518
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHILDREN'S ZYRTEC HIVES RELIEF at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
CHILDREN'S ZYRTEC HIVES RELIEF
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-005Nov 16, 2007DISCNYesNo6,455,533► SubscribeY ► Subscribe
J And J Consumer Inc
CHILDREN'S ZYRTEC HIVES RELIEF
cetirizine hydrochloride
TABLET, CHEWABLE;ORAL021621-006Nov 16, 2007DISCNYesNo6,455,533► SubscribeY ► Subscribe
J And J Consumer Inc
CHILDREN'S ZYRTEC HIVES RELIEF
cetirizine hydrochloride
SYRUP;ORAL022155-001Nov 16, 2007OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CHILDREN'S ZYRTEC HIVES RELIEF

Country Document Number Estimated Expiration
Denmark0994710► Subscribe
Portugal994710► Subscribe
China1261799► Subscribe
Hong Kong1029060► Subscribe
Australia8201598► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CHILDREN'S ZYRTEC HIVES RELIEF

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00085Netherlands► SubscribePRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
01C/045Belgium► SubscribePRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Johnson and Johnson
QuintilesIMS
Healthtrust
Daiichi Sankyo
Chubb
Dow
AstraZeneca
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot